Literature DB >> 20478

Phenothiazine phototoxicity: toxic chlorpromazine photoproducts.

B Ljunggren.   

Abstract

The effect of preirradiated chlorpromazine (CPZ) solutions has been studied in vivo in the guinea pig and in vitro in a yeast culture. With intracutaneous administration of CPZ solutions preirradiated with long-wave ultraviolet radiation (UVA), an inflammatory response was attained equaling the response achieved when nonirradiated solutions were injected and the skin of the animals was subsequently irradiated with UVA. Preirradiated CPZ was not toxic to the yeast culture. During irradiation the pH of the CPZ solution changed, indicating an accumulation of acid photoproducts. Nonphototoxic phenothiazines and related tricyclic drugs failed to change their pH following irradiation whereas phototoxic compounds behaved like CPZ. The low pH alone could not account for the inflammatory response in vivo, as neutralized irradiated CPZ solutions still induced inflammation, and acidified, nonirradiated solutions failed to cause a reaction. CPZ phototoxicity seems mainly to be due to the effect of photoproducts. The nature of these is not known, but it is suggested that the stable free radical of CPZ might be an active principle.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20478     DOI: 10.1111/1523-1747.ep12510313

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Experimental studies on the mechanism of benoxaprofen photoreactions.

Authors:  B Ljunggren; M Bjellerup; H Möller
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

2.  Photochemical inactivation of deoxyribonucleic and ribonucleic acid viruses by chlorpromazine.

Authors:  C V Hanson
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

3.  Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline.

Authors:  J Pinto; Y P Huang; R S Rivlin
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.